CBS catalyses the committing step in this pathway and is subject to multilevel regulation.51 Recent studies have shown the oncogenic role of CBS in colon and ovarian cancer models.52–55 We observed sustained upregulation of CBS in erastin-resistant cells, and further elucidated that upregulation of CBS was sufficient to render ferroptosis resistance. The gene discussed is CBS; the disease is ovarian carcinoma.